Viewing Study NCT06958835


Ignite Creation Date: 2025-12-24 @ 10:08 PM
Ignite Modification Date: 2026-01-01 @ 8:23 AM
Study NCT ID: NCT06958835
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2025-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Linezolid Plus Standard of Care
Sponsor: University Hospital, Basel, Switzerland
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2025-00655; am23Khanna3
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View